Release Date: 28/07/10 08:26 Summary: Quarterly Activities and Cashflow Report Price Sensitive: Yes Download Document 1.43MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%